Clinical Trial Update: Gut Microbiota Modulation With Synbiotics After Acute Coronary Syndrome [NA]

View source ↗

Summary

Clinical trial evaluating gut microbiota modulation with synbiotics after acute coronary syndrome; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Synbiotics

Snippet

Sponsor: Centre Hospitalier de Bienne | Conditions: Atheroscleroses, Coronary, Microbiota | NA | Status: NOT_YET_RECRUITING